oral glp-1 meds A Pill to Fight Obesity Is on the Verge of Approval Clinically backed oral GLP Foundayo vs Rybelsus: The Oral

This includes potential liver or kidney toxicity, severe allergic reactions, and rare conditions such as Stevens-Johnson Syndrome

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

doi: 10.3389/fphar.2014.00260 Received 09 July 2014 Accepted 08 November 2014 Published 27 November 2014 Volume 5 - 2014 Edited by Alfonso Pompella, Universit di Pisa, Italy Reviewed by Salvatore Salomone, Catania University, Italy

Blandini F, Greenamyre JT